AbbVie Inc.
ABBVUpdated . Prices are snapshots and may be delayed.
AbbVie Inc. price chart
AI Outlook for AbbVie Inc.
Bullish postureAbbVie shows a bullish technical stance, with the short-term average above the long-term average. Momentum is positive, and the relative strength index sits at 68. The stock trades just below its 52-week high, about -2.7% away, while the 30-day price gain is +10.6%.
- Long-term trend+22.0% vs 200-day average
- Medium-term trend+8.8% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Updated 9h ago. Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
AbbVie Inc. performance
About AbbVie Inc.
AbbVie Inc. is a biotechnology company based in the United States, listed on NEW YORK STOCK EXCHANGE, INC. since 2013 (ticker ABBV).
The shares trade at a price-to-earnings ratio of 74.7. The dividend yield is 4.47%.
AbbVie Inc. market data
What is the price of AbbVie Inc. today?
AbbVie Inc. (ABBV) is at $285.42, +0.64% on the day.
What is the 52-week range of AbbVie Inc.?
Over the past year AbbVie Inc. has traded between $190.75 and $291.40. It is currently 94% of the way up that range.
What is the P/E ratio of AbbVie Inc.?
AbbVie Inc. trades at a price-to-earnings ratio of 74.7.
Similar stocks
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.